The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users

Autor: Creinin, Mitchell D., Angulo, Alicyoy, Colli, Enrico, Archer, David F.
Zdroj: In Contraception December 2023 128
Databáze: ScienceDirect